Alector, Inc. (ALEC)
Develops antibody treatments to slow brain diseases like Alzheimer's and Parkinson's.
$1.52+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+4.5%
The outlook
Alector is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst coverage shows a notably bullish average price target sitting roughly 105% above the current price, though the overall sentiment leans bearish. The stock reflects a significant disconnect between near-term momentum and longer-term analyst expectations.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Price targetAvg target +105% vs current price
Analyst price target
~12-month · 5 analysts$3.10average target+104.6% vs now
Now $1.52
Low $1.00High $6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$168.2M
52-wk high
$3.40
52-wk low
$1.09
50-day avg
$1.80
200-day avg
$1.91
Trailing P/E
—